
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Interleukin-13 is overexpressed in cutaneous T-cell lymphoma cells and regulates their proliferation
Larisa J. Geskin, Sara Viragova, Donna B. Stolz, et al.
Blood (2015) Vol. 125, Iss. 18, pp. 2798-2805
Open Access | Times Cited: 141
Larisa J. Geskin, Sara Viragova, Donna B. Stolz, et al.
Blood (2015) Vol. 125, Iss. 18, pp. 2798-2805
Open Access | Times Cited: 141
Showing 51-75 of 141 citing articles:
The Microenvironment’s Role in Mycosis Fungoides and Sézary Syndrome: From Progression to Therapeutic Implications
Alessandro Pileri, Alba Guglielmo, Vieri Grandi, et al.
Cells (2021) Vol. 10, Iss. 10, pp. 2780-2780
Open Access | Times Cited: 23
Alessandro Pileri, Alba Guglielmo, Vieri Grandi, et al.
Cells (2021) Vol. 10, Iss. 10, pp. 2780-2780
Open Access | Times Cited: 23
JAK3 Is Expressed in the Nucleus of Malignant T Cells in Cutaneous T Cell Lymphoma (CTCL)
Chella Krishna Vadivel, Maria Gluud, Sara Torres‐Rusillo, et al.
Cancers (2021) Vol. 13, Iss. 2, pp. 280-280
Open Access | Times Cited: 21
Chella Krishna Vadivel, Maria Gluud, Sara Torres‐Rusillo, et al.
Cancers (2021) Vol. 13, Iss. 2, pp. 280-280
Open Access | Times Cited: 21
Development of Nodular Lesions after Dupilumab Therapy in Erythrodermic Mycosis Fungoides with Interleukin-13 Receptor alpha2 Expression
Mina Hashimoto, Tomomitsu Miyagaki, Reo Komaki, et al.
Acta Dermato Venereologica (2022) Vol. 102, pp. adv00766-adv00766
Open Access | Times Cited: 14
Mina Hashimoto, Tomomitsu Miyagaki, Reo Komaki, et al.
Acta Dermato Venereologica (2022) Vol. 102, pp. adv00766-adv00766
Open Access | Times Cited: 14
Safety and Danger Considerations of Novel Treatments for Atopic Dermatitis in Context of Primary Cutaneous Lymphomas
Karol Kołkowski, Magdalena Trzeciak, Małgorzata Sokołowska‐Wojdyło
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13388-13388
Open Access | Times Cited: 20
Karol Kołkowski, Magdalena Trzeciak, Małgorzata Sokołowska‐Wojdyło
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13388-13388
Open Access | Times Cited: 20
Integrated transcriptome and trajectory analysis of cutaneous T-cell lymphoma identifies putative precancer populations
Jingjing Ren, Rihao Qu, Nur-Taz Rahman, et al.
Blood Advances (2022) Vol. 7, Iss. 3, pp. 445-457
Open Access | Times Cited: 13
Jingjing Ren, Rihao Qu, Nur-Taz Rahman, et al.
Blood Advances (2022) Vol. 7, Iss. 3, pp. 445-457
Open Access | Times Cited: 13
Cytokine Profile in Development of Glioblastoma in Relation to Healthy Individuals
Paweł Jarmużek, Piotr Defort, Marcin Kot, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16206-16206
Open Access | Times Cited: 7
Paweł Jarmużek, Piotr Defort, Marcin Kot, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16206-16206
Open Access | Times Cited: 7
A single center phase II study of ixazomib in patients with relapsed or refractory cutaneous or peripheral T‐cell lymphomas
Philip S. Boonstra, Avery Polk, Noah A. Brown, et al.
American Journal of Hematology (2017) Vol. 92, Iss. 12, pp. 1287-1294
Open Access | Times Cited: 24
Philip S. Boonstra, Avery Polk, Noah A. Brown, et al.
American Journal of Hematology (2017) Vol. 92, Iss. 12, pp. 1287-1294
Open Access | Times Cited: 24
14-3-3z sequesters cytosolic T-bet, upregulating IL-13 levels in T C 2 and CD8 + lymphocytes from patients with scleroderma
Sandra Cascio, Thomas A. Medsger, William F. Hawse, et al.
Journal of Allergy and Clinical Immunology (2017) Vol. 142, Iss. 1, pp. 109-119.e6
Open Access | Times Cited: 23
Sandra Cascio, Thomas A. Medsger, William F. Hawse, et al.
Journal of Allergy and Clinical Immunology (2017) Vol. 142, Iss. 1, pp. 109-119.e6
Open Access | Times Cited: 23
What Cytokines Can Tell Us About the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)
Marshall E. Kadin
Aesthetic Surgery Journal (2019) Vol. 39, Iss. Supplement_1, pp. S28-S35
Open Access | Times Cited: 22
Marshall E. Kadin
Aesthetic Surgery Journal (2019) Vol. 39, Iss. Supplement_1, pp. S28-S35
Open Access | Times Cited: 22
CD147-Cyclophilin a Interactions Promote Proliferation and Survival of Cutaneous T-Cell Lymphoma
Minami Sakamoto, Tomomitsu Miyagaki, Hiroaki Kamijo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 7889-7889
Open Access | Times Cited: 17
Minami Sakamoto, Tomomitsu Miyagaki, Hiroaki Kamijo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 7889-7889
Open Access | Times Cited: 17
NLRP3 Regulates IL-4 Expression in TOX+ CD4+ T Cells of Cutaneous T Cell Lymphoma to Potentially Promote Disease Progression
Enrique Huanosta-Murillo, Marcela Alcántara‐Hernández, Brenda Hernández-Rico, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 16
Enrique Huanosta-Murillo, Marcela Alcántara‐Hernández, Brenda Hernández-Rico, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 16
Mycosis fungoides and Sézary syndrome
Constanze Jonak, Julia Tittes, Patrick M. Brunner, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2021) Vol. 19, Iss. 9, pp. 1307-1334
Open Access | Times Cited: 16
Constanze Jonak, Julia Tittes, Patrick M. Brunner, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2021) Vol. 19, Iss. 9, pp. 1307-1334
Open Access | Times Cited: 16
Discordant lymphomas of classic Hodgkin lymphoma and peripheral T-cell lymphoma following dupilumab treatment for atopic dermatitis
Kumi Nakazaki, Mina Yoshida, Yosuke Masamoto, et al.
International Journal of Hematology (2022) Vol. 116, Iss. 3, pp. 446-452
Closed Access | Times Cited: 11
Kumi Nakazaki, Mina Yoshida, Yosuke Masamoto, et al.
International Journal of Hematology (2022) Vol. 116, Iss. 3, pp. 446-452
Closed Access | Times Cited: 11
Elevated serum IL‐13 level is associated with increased Treg cells in tumor microenvironment and disease progression of diffuse large B‐cell lymphoma
Xiao Li, Mengke Liu, Qing Shi, et al.
Hematological Oncology (2022) Vol. 41, Iss. 2, pp. 230-238
Closed Access | Times Cited: 11
Xiao Li, Mengke Liu, Qing Shi, et al.
Hematological Oncology (2022) Vol. 41, Iss. 2, pp. 230-238
Closed Access | Times Cited: 11
Unveiling tumor immune evasion mechanisms: abnormal expression of transporters on immune cells in the tumor microenvironment
Lu Chen, Yuchen Wang, Qingqing Hu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Lu Chen, Yuchen Wang, Qingqing Hu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Advancements in the treatment of mycosis fungoides and Sézary syndrome: monoclonal antibodies, immunotherapies, and Janus kinase inhibitors
Iman Quadri, John Reneau, Walter Hanel, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Iman Quadri, John Reneau, Walter Hanel, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Interleukin-25 is involved in cutaneous T-cell lymphoma progression by establishing a T helper 2-dominant microenvironment
Rina Nakajima, Tomomitsu Miyagaki, Masahiro Hirakawa, et al.
British Journal of Dermatology (2017) Vol. 178, Iss. 6, pp. 1373-1382
Closed Access | Times Cited: 21
Rina Nakajima, Tomomitsu Miyagaki, Masahiro Hirakawa, et al.
British Journal of Dermatology (2017) Vol. 178, Iss. 6, pp. 1373-1382
Closed Access | Times Cited: 21
Dupilumab and cutaneous T-cell lymphoma
Dirk M. Elston
Journal of the American Academy of Dermatology (2020) Vol. 83, Iss. 1, pp. 33-34
Open Access | Times Cited: 17
Dirk M. Elston
Journal of the American Academy of Dermatology (2020) Vol. 83, Iss. 1, pp. 33-34
Open Access | Times Cited: 17
CCR7 in Blood Cancers – Review of Its Pathophysiological Roles and the Potential as a Therapeutic Target
Carlos Cuesta‐Mateos, Fernando Terrón, Marco Herling
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 15
Carlos Cuesta‐Mateos, Fernando Terrón, Marco Herling
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 15
The Role of Tumor Microenvironment in the Pathogenesis of Sézary Syndrome
Denis Miyashiro, Bruno de Castro e Souza, Marina Passos Torrealba, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 936-936
Open Access | Times Cited: 10
Denis Miyashiro, Bruno de Castro e Souza, Marina Passos Torrealba, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 936-936
Open Access | Times Cited: 10
Potential role of PRKCSH in lung cancer: bioinformatics analysis and a case study of Nano ZnO
Ridan Lei, Meiling Zhou, Shusheng Zhang, et al.
Nanoscale (2022) Vol. 14, Iss. 12, pp. 4495-4510
Closed Access | Times Cited: 10
Ridan Lei, Meiling Zhou, Shusheng Zhang, et al.
Nanoscale (2022) Vol. 14, Iss. 12, pp. 4495-4510
Closed Access | Times Cited: 10
GATA‐3 in T‐cell lymphoproliferative disorders
Carlos Murga‐Zamalloa, Ryan A. Wilcox
IUBMB Life (2019) Vol. 72, Iss. 1, pp. 170-177
Open Access | Times Cited: 17
Carlos Murga‐Zamalloa, Ryan A. Wilcox
IUBMB Life (2019) Vol. 72, Iss. 1, pp. 170-177
Open Access | Times Cited: 17
Normal and cancer fibroblasts differentially regulate TWIST1, TOX and cytokine gene expression in cutaneous T-cell lymphoma
Syed Jafar Mehdi, A. Moerman, Henry K. Wong
BMC Cancer (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 14
Syed Jafar Mehdi, A. Moerman, Henry K. Wong
BMC Cancer (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 14
Emerging drugs for the treatment of cutaneous T-cell lymphoma
Melissa Cheng, Jasmine Zain, Steven T. Rosen, et al.
Expert Opinion on Emerging Drugs (2022) Vol. 27, Iss. 1, pp. 45-54
Open Access | Times Cited: 9
Melissa Cheng, Jasmine Zain, Steven T. Rosen, et al.
Expert Opinion on Emerging Drugs (2022) Vol. 27, Iss. 1, pp. 45-54
Open Access | Times Cited: 9
Is blocking IL‐4 receptor alpha beneficial for patients with mycosis fungoides or Sézary syndrome?
Makoto Sugaya
The Journal of Dermatology (2021) Vol. 48, Iss. 5
Closed Access | Times Cited: 12
Makoto Sugaya
The Journal of Dermatology (2021) Vol. 48, Iss. 5
Closed Access | Times Cited: 12